Pfizer Drugs
- All
- News
- Videos
-
Pfizer Names Meenakshi Nevatia As Managing Director
Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
Pfizer In Talks To Buy Drugmaker For $5 Billion: Report
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
Pfizer To Sell Drugs To World's Poorest Countries On Not-For-Profit Basis
US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs at a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
-
Pfizer Recalls Hypertension Drug Accupril After Elevated Levels Of Cancer-Causing Chemicals Found
Pfizer had last month also recalled some batches of another blood pressure drug Accuretic and two authorised cheaper versions due to the presence of possible carcinogen.
-
US Is Considering Second Covid Booster For 65+
Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Pfizer, Moderna Vaccines Safe During Pregnancy: EU Drug Regulator
Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
-
Pfizer Names Meenakshi Nevatia As Managing Director
Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
Pfizer In Talks To Buy Drugmaker For $5 Billion: Report
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
Pfizer To Sell Drugs To World's Poorest Countries On Not-For-Profit Basis
US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs at a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
-
Pfizer Recalls Hypertension Drug Accupril After Elevated Levels Of Cancer-Causing Chemicals Found
Pfizer had last month also recalled some batches of another blood pressure drug Accuretic and two authorised cheaper versions due to the presence of possible carcinogen.
-
US Is Considering Second Covid Booster For 65+
Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Pfizer, Moderna Vaccines Safe During Pregnancy: EU Drug Regulator
Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
US Health Regulator Authorizes Pfizer's Covid Pill
The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.
